Arkolith/Insider Trading/NBIX/Form 4

Delaet Ingrid

Chief Regulatory OfficerNEUROCRINE BIOSCIENCES INC (NBIX) · full profile →Form 4 · filed Jul 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.6M
Net Open-Market Flow
-$2.6M
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)8K$103.52$873K25K
Jul 9, 2026Sell(S)8K$178.72$1.5M16K
Jul 8, 2026Option exercise(M)3K$103.52$283K19K
Jul 8, 2026Sell(S)3K$178.54$489K16K
Jul 7, 2026Option exercise(M)3K$103.52$352K20K
Jul 7, 2026Sell(S)3K$178.57$607K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)8K—$07K
Jul 8, 2026Option exercise(M)3K—$016K
Jul 7, 2026Option exercise(M)3K—$019K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001965808-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML